Oncology

Understand your risks so you can understand your options.
Learn about your risk of developing certain inherited cancers
before they happen.
About

Genetic testing for hereditary and somatic cancers can provide life-changing results in affected patients and their relatives, accompanied by potential actionable steps for genetic-related cancers. With many different applications of genetic testing to detect and care for cancer, we can guide you in selecting the right options to enhance the treatment of your patients suffering from hereditary cancers. Having identified genetic variants associated with oncological diseases in more than 200 different genes, we can provide a comprehensive range to foster cancer diagnosis, prognosis, treatment selection, and monitoring.

DIPLOIDE´s DIPCANCER cancer panels can help determine if you carry a mutation that would put you at an increased risk for cancer.

Diploide provides a wide range of clinical and research solutions for oncology.

Comprehensive Cancer Panel

Based on expert curation of literature and scientific evidence.

Go

Cancer Discovery Panel

DIPLOIDE cancer panels are designed to identify the four classes of actionable genomic abnormalities.

Go

Breast & Ovarian Cancer Panel

Information on genes associated with hereditary breast and ovarian cancer (HBOC).

Go

Lung Cancer Panel

It covers 11 genes with direct therapeutic implications for 20 targeted drugs, including those recommended in the latest NCCN guidelines.

Go

Colorectal Cancer Panel

It uses the capture of the target region and NGS to examine 7 genes involved in therapies targeting RCC.

Go

Targeted Drug Therapy Panel

The DIPLOIDE Targeted Drug Therapy Panel examines all selected exons and introns.

Go

UHD 1000px DIPLOIDE MINIMALIST logo.png

EXPLORE

LEGAL

CONNECT WITH US

Facebook

Twitter

Instagram

YouTube

Linkedin

© 2020 by DIPLOIDE GENETICS CORPORATE

1440 G St NW Washington, DC 20005

+1 833 DIPLOID

Contact Us